Evidence map›Paper›PMID 32811840›Full record

ArticleNPJ schizophrenia2020

Reduced levels of circulating adhesion molecules in adolescents with early-onset psychosis.

Kirsten Wedervang-Resell, Thor Ueland, Pål Aukrust, Svein Friis, Kirsten B Holven, Cecilie H Johannessen, Tove Lekva, Vera Lonning, Runar E Smelror, Attila Szabo and 3 more

Open access · goldAbstract read
In one paragraph

Article in NPJ schizophrenia, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Unraveling the impact ofBrain communications · 2026
    Article
  3. Network-based drug repurposing for schizophrenia.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 2 countries.

Kirsten Wedervang-ResellNORMENT Center of Excellence, Institute of Clinical Medicine, University of Oslo, Oslo, Norway. kirsten.wedervang-resell@medisin.uio.no.ORCID http://orcid.org/0000-0002-2856-5412
Thor UelandResearch Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
Pål AukrustResearch Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
Svein FriisDivision of Mental Health and Addiction, Department of Psychiatric Research and Development, Oslo University Hospital, Oslo, Norway.
Kirsten B HolvenDepartment of Nutrition, Institute for Basic Medical Sciences, University of Oslo, PO Box 1046, Blindern, 0317, Oslo, Norway.
Cecilie H JohannessenNORMENT Center of Excellence, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Tove LekvaResearch Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
Vera LonningNORMENT Center of Excellence, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Runar E SmelrorNORMENT Center of Excellence, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Attila SzaboNORMENT Center of Excellence, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Ole A AndreassenNORMENT Center of Excellence, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Anne M MyhreDivision of Mental Health and Addiction, Department of Psychiatric Research and Development, Oslo University Hospital, Oslo, Norway.
Ingrid AgartzNORMENT Center of Excellence, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Oslo University Hospital · NOUniversity of Oslo · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is suggested that neurodevelopmental abnormalities are involved in the disease mechanisms of psychotic disorders. Although cellular adhesion molecules (CAMs) participate in neurodevelopment, modulate blood-brain barrier permeability, and facilitate leukocyte migration, findings concerning their systemic levels in adults with psychosis are inconsistent. We examined plasma levels and mRNA expression in peripheral blood mononuclear cells (PBMCs) of selected CAMs in adolescents with early-onset psychosis (EOP) aged 12-18 years (n = 37) and age-matched healthy controls (HC) (n = 68). EOP patients exhibited significantly lower circulating levels of soluble platelet selectin (~-22%) and soluble vascular cell adhesion molecule-1 (~-14%) than HC. We found no significant associations with symptom severity. PSEL mRNA expression was increased in PBMCs of patients and significantly negatively correlated to duration of illness. These findings suggest a role for CAMs in the pathophysiology of psychotic disorders.

Identifiers

PMID32811840
PMCPMC7434772
OpenAlexW3050386681

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.